Kyverna Therapeutics (KYTX) Earnings Date & Reports

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KYTX is expected to report earnings to rise 17.54% to -101 cents per share on August 18

Kyverna Therapeutics KYTX Stock Earnings Reports

Q2'25

Est.

$-1.02

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.11

The last earnings report on March 27 showed earnings per share of -86 cents, beating the estimate of -94 cents. With 307.78K shares outstanding, the current market capitalization sits at 123.17M.

View a ticker or compare two or three

Compare

KYTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For KYTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

5980 Horton Street

Phone

+1 510 925-2492

Employees

Web

https://www.kyvernatx.com